ETF Managers Group’s Takeda Pharmaceutical TAK Stock Holding History

ETF Managers Group’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$148K	Buy	+9,004	New	+$143K	﹤0.01%	609
2022 Q4	–	Sell	-12,846	Closed	-$167K	–	677
2022 Q3	$167K	Sell	12,846 -128	-1%	-$1.78K	0.01%	616
2022 Q2	$180K	Sell	12,974 -2,686	-17%	-$38.3K	0.01%	655
2022 Q1	$226K	Sell	15,660 -12,757	-45%	-$187K	﹤0.01%	595
2021 Q4	$386K	Sell	28,417 -1,648	-5%	-$23.1K	0.01%	563
2021 Q3	$490K	Buy	30,065 +8,362	+39%	+$140K	0.01%	539
2021 Q2	$365K	Buy	21,703 +930	+4%	+$15.8K	0.01%	575
2021 Q1	$381K	Buy	20,773 +405	+2%	+$7.29K	0.01%	549
2020 Q4	$370K	Buy	20,368 +1,071	+6%	+$18.8K	0.01%	483
2020 Q3	$350K	Buy	19,297 +12,052	+166%	+$219K	0.01%	397
2020 Q2	$131K	Buy	+7,245	New	+$130K	﹤0.01%	578

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

ETF Managers Group's TAK Position: Q1 2023 in Review

ETF Managers Group opened a new position in Takeda Pharmaceutical (TAK) in Q1 2023: 9,004 shares worth $148K. The stake represents ﹤0.01% of the portfolio and ranks #609 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in TAK as recently as Q3 2022.

ETF Managers Group first reported a position in TAK in Q2 2020 and has held it in 11 quarters since. The position peaked at $490K in Q3 2021. 300 funds tracked by Wall St. Rank hold TAK as of Q1 2023.

ETF Managers Group held 9,004 shares of Takeda Pharmaceutical worth $148K as of Q1 2023.
Takeda Pharmaceutical was a new ETF Managers Group position in Q1 2023.
Takeda Pharmaceutical made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #609 holding.
ETF Managers Group first reported a position in Takeda Pharmaceutical in Q2 2020 and has held it in 11 quarters since.
ETF Managers Group's Takeda Pharmaceutical position peaked at $490K in Q3 2021.
300 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.